Biotech Odyssey, Medical Device Firm Mobia File for US IPOs

Healthcare companies are lining up to go public with a drug developer and medical device company joining a pool of peers seeking to advance public listing plans amid robust investor demand for biotech stocks.

Odyssey Therapeutics Inc., which is focused on treating patients suffering from autoimmune and inflammatory diseases, filed paperwork with the US Securities and Exchange Commission, as did Austin-based Mobia Medical Inc.